CTCL

9 registered clinical trials studyying CTCL — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL NCT06854653	Prescient Therapeutics, Ltd.	Phase 2
Recruiting	Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL NCT06470451	Soligenix	Phase 3
Terminated	Ritlecitinib in CTCL NCT05879458	Icahn School of Medicine at Mount Sinai	Phase 2
Active Not Recruiting	Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL NCT03240211	University of Virginia	Phase 1
Recruiting	StrataCTX® as a Steroid Sparing Device NCT04087629	Columbia University	N/A
Completed	A Study of ABT-199 (Venetoclax) for Cutaneous T Cell Lymphoma (CTCL) NCT04171791	Yale University	Phase 1
Completed	A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL NCT03239392	Bioniz Therapeutics	Phase 1 / Phase 2
Withdrawn	Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCL NCT02757248	Anne Beaven, MD	Phase 1
Terminated	A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative NCT02556463	MedImmune LLC	Phase 1